These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 33988334)

  • 1. The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression.
    Thieme CJ; Anft M; Paniskaki K; Blazquez-Navarro A; Doevelaar A; Seibert FS; Hoelzer B; Justine Konik M; Meister TL; Pfaender S; Steinmann E; Moritz Berger M; Brenner T; Kölsch U; Dolff S; Roch T; Witzke O; Schenker P; Viebahn R; Stervbo U; Westhoff TH; Babel N
    Transplantation; 2021 Oct; 105(10):2156-2164. PubMed ID: 33988334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and Vaccination.
    Leacy EJ; Teh JW; O'Rourke AM; Brady G; Gargan S; Conlon N; Scott J; Dunne J; Phelan T; Griffin MD; Power J; Mooney A; Naughton A; Kiersey R; Gardiner M; O'Brien C; Mullan R; Flood R; Clarkson M; Townsend L; O'Shaughnessy M; Dyer AH; Moran B; Fletcher JM; Zgaga L; Little MA;
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient.
    Babel N; Anft M; Blazquez-Navarro A; Doevelaar AAN; Seibert FS; Bauer F; Rohn BJ; Hoelzer B; Thieme CJ; Roch T; Meister TL; Pfaender S; Steinmann E; Dittmer U; Schenker P; Amann K; Viebahn R; Stervbo U; Westhoff TH
    Am J Transplant; 2020 Nov; 20(11):3210-3215. PubMed ID: 32777178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust and Persistent B- and T-Cell Responses after COVID-19 in Immunocompetent and Solid Organ Transplant Recipient Patients.
    Zavaglio F; Frangipane V; Morosini M; Gabanti E; Zelini P; Sammartino JC; Ferrari A; Gregorini M; Rampino T; Asti A; Seminari E; Di Matteo A; Cattadori B; Pellegrini C; Tonello S; Mallela VR; Minisini R; Rizzi M; Sainaghi PP; Meloni F; Lilleri D; Baldanti F
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
    Sattler A; Schrezenmeier E; Weber UA; Potekhin A; Bachmann F; Straub-Hohenbleicher H; Budde K; Storz E; Proß V; Bergmann Y; Thole LM; Tizian C; Hölsken O; Diefenbach A; Schrezenmeier H; Jahrsdörfer B; Zemojtel T; Jechow K; Conrad C; Lukassen S; Stauch D; Lachmann N; Choi M; Halleck F; Kotsch K
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34101623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
    Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T
    Front Immunol; 2022; 13():817905. PubMed ID: 35185909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view.
    von Metzler I; Campe J; Huenecke S; Raab MS; Goldschmidt H; Schubert R; Rabenau HF; Ciesek S; Serve H; Ullrich E
    J Mol Med (Berl); 2022 Mar; 100(3):463-470. PubMed ID: 34657968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.
    Kirchner T; Heinrich S; Bonifacius A; Engel B; Ruhl L; Pink I; Thomas N; Martens J; Hoeper MM; Blasczyk R; Wedemeyer H; Jaeckel E; Li Y; Falk CS; Eiz-Vesper B; Taubert R
    PLoS One; 2022; 17(11):e0276929. PubMed ID: 36322587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
    Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F
    Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People.
    Demaret J; Corroyer-Simovic B; Alidjinou EK; Goffard A; Trauet J; Miczek S; Vuotto F; Dendooven A; Huvent-Grelle D; Podvin J; Dreuil D; Faure K; Deplanque D; Bocket L; Duhamel A; Labreuche J; Sobaszek A; Hisbergues M; Puisieux F; Labalette M; Lefèvre G
    Front Immunol; 2021; 12():778679. PubMed ID: 34868051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 Cross-Reactive B and T Cell Responses in Kidney Transplant Patients.
    Paniskaki K; Anft M; Thieme CJ; Skrzypczyk S; Konik MJ; Dolff S; Westhoff TH; Nienen M; Stittrich A; Stervbo U; Witzke O; Heine G; Roch T; Babel N
    Transplant Proc; 2022; 54(6):1455-1464. PubMed ID: 35489983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses.
    Bonifacius A; Tischer-Zimmermann S; Dragon AC; Gussarow D; Vogel A; Krettek U; Gödecke N; Yilmaz M; Kraft ARM; Hoeper MM; Pink I; Schmidt JJ; Li Y; Welte T; Maecker-Kolhoff B; Martens J; Berger MM; Lobenwein C; Stankov MV; Cornberg M; David S; Behrens GMN; Witzke O; Blasczyk R; Eiz-Vesper B
    Immunity; 2021 Feb; 54(2):340-354.e6. PubMed ID: 33567252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.
    Hartzell S; Bin S; Benedetti C; Haverly M; Gallon L; Zaza G; Riella LV; Menon MC; Florman S; Rahman AH; Leech JM; Heeger PS; Cravedi P
    Am J Transplant; 2020 Nov; 20(11):3149-3161. PubMed ID: 32786152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young men.
    Le Bert N; Chia WN; Wan WY; Teo AKJ; Chong SZ; Tan N; Tan DSC; Chia A; Tan IB; Kunasegaran K; Chua QX; Abdad MY; Ng ASH; Vasoo S; Ang JX; Lee MS; Sun L; Fang J; Zhu F; Cook AR; Aw TC; Huang J; Tam C; Lee FS; Clapham H; Goh EJ; Peou MSS; Tan SP; Ong SK; Wang LF; Bertoletti A; Hsu LY; Ong BC
    Emerg Microbes Infect; 2021 Dec; 10(1):2141-2150. PubMed ID: 34709140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression.
    Manjappa S; Phi HQ; Lee LW; Onstad L; Gill DB; Connelly-Smith L; Krakow EF; Flowers ME; Carpenter PA; Hill JA; Lee SJ
    Transplant Cell Ther; 2022 Nov; 28(11):784.e1-784.e9. PubMed ID: 36058550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
    Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
    Front Immunol; 2021; 12():797919. PubMed ID: 34975908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents.
    Paniskaki K; Goretzki S; Anft M; Konik MJ; Lechtenberg K; Vogl M; Meister TL; Pfaender S; Zettler M; Jäger J; Dolff S; Westhoff TH; Rohn H; Felderhoff-Mueser U; Stervbo U; Witzke O; Dohna-Schwake C; Babel N
    BMC Infect Dis; 2023 Nov; 23(1):818. PubMed ID: 37993788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
    Ewer KJ; Barrett JR; Belij-Rammerstorfer S; Sharpe H; Makinson R; Morter R; Flaxman A; Wright D; Bellamy D; Bittaye M; Dold C; Provine NM; Aboagye J; Fowler J; Silk SE; Alderson J; Aley PK; Angus B; Berrie E; Bibi S; Cicconi P; Clutterbuck EA; Chelysheva I; Folegatti PM; Fuskova M; Green CM; Jenkin D; Kerridge S; Lawrie A; Minassian AM; Moore M; Mujadidi Y; Plested E; Poulton I; Ramasamy MN; Robinson H; Song R; Snape MD; Tarrant R; Voysey M; Watson MEE; Douglas AD; Hill AVS; Gilbert SC; Pollard AJ; Lambe T;
    Nat Med; 2021 Feb; 27(2):270-278. PubMed ID: 33335323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.